In 80 curative resections for rectal cancers, there was a tendency that the DFS rates were better in those cases immunonegative for AFAP1L1 expression as compared to the strongly immunopositive cases (Fig.1C). The gene discussed is AFAP1L1; the disease is rectal cancer.